Financial Metrics Check: Neogenomics Inc (NEO)’s Ratios for Trailing Twelve Months

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

As of close of business last night, Neogenomics Inc’s stock clocked out at $6.21, up 0.16% from its previous closing price of $6.2. In other words, the price has increased by $0.16 from its previous closing price. On the day, 1.79 million shares were traded. NEO stock price reached its highest trading level at $6.32 during the session, while it also had its lowest trading level at $6.15.

Ratios:

To gain a deeper understanding of NEO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.58 and its Current Ratio is at 3.92. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 06 ’25 when Sherman Jeffrey Scott bought 20,000 shares for $5.62 per share. The transaction valued at 112,322 led to the insider holds 188,332 shares of the business.

Zook Anthony P. bought 17,900 shares of NEO for $99,954 on Aug 06 ’25. The Chief Executive Officer now owns 38,066 shares after completing the transaction at $5.58 per share. On May 27 ’25, another insider, Kelly Michael Aaron, who serves as the Director of the company, bought 5,000 shares for $7.60 each. As a result, the insider paid 38,000 and bolstered with 5,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 802201600 and an Enterprise Value of 1050277248. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.16 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 1.524 whereas that against EBITDA is -135.067.

Stock Price History:

The Beta on a monthly basis for NEO is 1.58, which has changed by -0.62925375 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $4.72. The 50-Day Moving Average of the stock is -7.22%, while the 200-Day Moving Average is calculated to be -43.46%.

Shares Statistics:

It appears that NEO traded 2.22M shares on average per day over the past three months and 2183380 shares per day over the past ten days. A total of 128.68M shares are outstanding, with a floating share count of 127.46M. Insiders hold about 1.33% of the company’s shares, while institutions hold 97.25% stake in the company. Shares short for NEO as of 1753920000 were 5018485 with a Short Ratio of 2.26, compared to 1751241600 on 4540073. Therefore, it implies a Short% of Shares Outstanding of 5018485 and a Short% of Float of 5.3600002.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.